Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Full Year 2024 Trading Update

26 Nov 2024 07:00

RNS Number : 5856N
IDOX PLC
26 November 2024
 

26 November 2024

Idox plc

('Idox', the 'Group' or the 'Company')

Full Year 2024 Trading Update

A strong performance with c.20% growth in revenue

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and geospatial data solutions to the public and asset-intensive sectors, today issues a trading update for its financial year ended 31 October 2024 ('FY24').

 

Group trading performance

 

We are pleased to report that Idox has delivered strong growth for FY24. This builds on the significant progress the Group has made over the past few years.

 

The Group delivered an order intake of c.£89m in FY24 (FY23: £82m), an increase of c.9% on the prior year, reflecting our high-quality customer base and strong market positions.

 

The Board expects to report (subject to external audit) revenue and adjusted EBITDA1 in line with expectations; revenue is expected to be up c.20% to c.£87.6m (FY23: £73.3m), with recurring revenue also up over the period to c.£54m (FY23: £45.5m), delivering a c.7% increase in full year adjusted EBITDA to c.£26.1m (FY23: £24.5m) and an adjusted EBITDA margin of c.30% (FY23: 33%).

 

The Group continued to generate good cash flow during the year and ended the year with a net debt2 position of c.£10.0m (£14.7m as at 31 October 2023).

 

Notice of results

 

The Group expects to report its FY24 results in late January 2025. Management intends to host a results webinar on the day. Please contact MHP to register your interest.

 

David Meaden, Chief Executive Officer of Idox commented:

 

"We are pleased to have delivered a strong performance in 2024, featuring a c.20% growth in revenue.

 

Our most recent acquisition, Emapsite, has added significant scale and expertise to our existing geospatial data capabilities, and has performed well in the year. We continue to be excited by the growth opportunities available in this sector, adding to our existing market leading public software capabilities. We continue to evaluate the opportunity for further acquisitions to enhance our offering and are optimistic on the pipeline as we move into 2025.

 

Whilst aware of wider economic and geopolitical uncertainties, the Group is well positioned and looks forward to reporting its FY24 results in January 2025, and also providing an update on the early progress made in FY25."

 

Definitions

1 Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

2 Net debt is defined as the aggregation of cash, bank borrowings and long-term bond. This differs from a similar measure under IFRS, which would also include lease liabilities as debt. The definition used is consistent with that used within the Group's banking arrangements.

For further information please contact:

 

Idox plc

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

+44 (0) 870 333 7101

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

Benjamin Cryer

Kate Bannatyne

Adam Telling

 

+44 (0) 20 7418 8900

MHP

Reg Hoare

Ollie Hoare

Matthew Taylor

About Idox plc

 

For more information see www.idoxplc.com @Idoxgroup

 

+ 44 (0) 7831 406117

idox@mhpgroup.com

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZMZMRKRGDZM
Date   Source Headline
29th May 20267:00 amRNSCancellation - IDOX Plc
26th May 20261:45 pmRNSRule 19.6(b) update
18th May 202610:22 amRNSHolding(s) in Company
12th May 20268:21 amRNSCompulsory Acquisition of Idox Shares
7th May 20263:52 pmRNSHolding(s) in Company
5th May 20267:00 amRNSAcceptance Level Update
28th Apr 20266:00 pmRNSIDOX
28th Apr 20267:00 amRNSProposed cancellation of Idox shares on AIM
27th Apr 20267:00 amRNSAcceptance Level Update
22nd Apr 20262:26 pmRNSForm 8.3 - Idox plc
22nd Apr 20261:00 pmRNSReplacement: Director/PDMR Shareholding
22nd Apr 202611:24 amRNSDirector/PDMR Shareholding
21st Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
21st Apr 20269:13 amBUSForm 8.3 - [IDOX PLC - 20 04 2026] - (CGWL)
21st Apr 20267:45 amRNSDisclosure Table
21st Apr 20267:00 amRNSOffer Declared Unconditional
20th Apr 20263:46 pmRNSUpdate on Letters of Intent
20th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
20th Apr 20269:12 amBUSForm 8.3 - [IDOX PLC - 17 04 2026] - (CGWL)
20th Apr 20267:00 amRNSAcceptance Level Update
17th Apr 20263:26 pmRNSForm 8.3 - IDOX PLC
17th Apr 20263:25 pmRNSForm 8.3 - Idox plc
17th Apr 20262:10 pmRNSHolding(s) in Company
17th Apr 20261:03 pmRNSForm 8.3 - IDOX PLC
17th Apr 202612:43 pmRNSForm 8.3 - Idox plc
17th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
17th Apr 20269:05 amBUSForm 8.3 - [IDOX PLC - 16 04 2026] - (CGWL)
17th Apr 20267:00 amRNSAcceptance Level Update
17th Apr 20267:00 amRNSForm 8.3 - Idox plc
16th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
16th Apr 20263:27 pmRNSForm 8.3 - IDOX PLC
16th Apr 20263:12 pmRNSForm 8.3 - Idox plc
16th Apr 20261:15 pmRNSForm 8.3 - IDOX PLC
16th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
16th Apr 20268:51 amBUSForm 8.3 - [IDOX PLC - 15 04 2026] - (CGWL)
16th Apr 20267:00 amRNSSatisfaction of Regulatory Conditions
15th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
15th Apr 20262:38 pmRNSForm 8.3 - Idox plc
15th Apr 20269:25 amBUSForm 8.3 - [IDOX PLC - 14 04 2026] - (CGWL)
15th Apr 20267:00 amRNSUpdate on Letters of Intent
14th Apr 20264:01 pmRNSForm 8.3 - Idox plc
14th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
14th Apr 20263:27 pmRNSForm 8.3 - IDOX PLC
14th Apr 20261:29 pmRNSForm 8.3 - IDOX PLC
14th Apr 202612:37 pmRNSForm 8.3 - Idox plc
14th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
14th Apr 202610:04 amBUSForm 8.3 - [IDOX PLC - 13 04 2026] - (CGWL)
14th Apr 20267:00 amRNSUpdate on Letters of Intent
13th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
13th Apr 202610:46 amBUSForm 8.3 - [IDOX PLC - 10 04 2026] - (CGWL)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.